• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6
Click for more information
0.12% $8.70

CLARITY PHARMACEUTICALS LTD - Charts / Financials

Market Cap $2.749B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 26/09/2024 (20 minute delay) ?
Day
Open $8.82   Day High $8.92   Day Low $8.57
Daily Volume 1715841
Bids   Sellers
Number Price Volume   Number Price Volume
2 $8.57 1665   1 $8.72 7454

Data source: Refinitiv

(20min delay)
Last
$8.70 		Change
0.010(0.12%) 		Mkt cap ! $2.749B
Open High Low Value Volume
$8.82 $8.92 $8.57 $14.92M 1.715M

Buyers (Bids)

No. Vol. Price($)
2 1665 $8.57
 

Sellers (Offers)

Price($) Vol. No.
$8.72 7454 1
View Market Depth
Last trade - 16.10pm 26/09/2024 (20 minute delay) ?
Last
$8.58 		  Change
0.010 ( 0.52 %)
Open High Low Volume
$8.83 $8.92 $8.57 168620
Last updated 15.59pm 26/09/2024 ?

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Legacy hits high-grade gold, silver and copper through drilling at NSW's Bauloora Legacy Minerals Holdings Ltd has found 468g/t of silver, 3.8g/t of gold, and 22% zinc-lead from drilling at the Bauloora play
QX Resources increases US lithium footprint with key agreements QX Resources Ltd has renegotiated one agreement and entered into another in relation to lithium projects in the United States.
SkyCity jumps 2% after copping A$3.6M fine from NZ High Court – far below AUSTRAC's fine NZ-based Skycity Entertainment has revealed it's been hit with a NZ$4.16M fine from New Zealand's High Court.
QMines jumps +4.6% on drill hits boasting high copper grades QMines (ASX:QML) described as "outstanding" its latest copper drill hits from Develin Creek revealed on Thursday.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.